BioElectronics Corporation (OTC: BIEL), a developer of medical technology products, announced today that it has expanded its Maryland headquarters by leasing an adjacent office suite to operate as a dedicated storage and fulfillment center. The expansion supports new commercial activity involving ActiPatch and RecoveryRx, following an agreement with Electrome Corporation.
Under a Fulfillment Services and Distribution Control Agreement, BioElectronics will provide inventory receiving, storage, order processing, packing, shipping coordination, and returns-management services for Electrome. Electrome is preparing for the direct-to-consumer launch of ActiPatch in newly designed branded packaging, and BioElectronics expects the expanded facility to process individual consumer orders generated through that channel. The facility will also support anticipated orders for RecoveryRx, an FDA-cleared prescription medical device for postoperative and musculoskeletal pain.
“This expansion represents more than an increase in physical space,” said Kelly Whelan, President of BioElectronics Corporation. “It strengthens our commercial infrastructure, supports Electrome’s planned ActiPatch launch, and positions BioElectronics to efficiently fulfill anticipated increased RecoveryRx demand. It also creates an additional service-based revenue opportunity alongside product sales.”
Erik A. Nilsen, PhD, Co-Founder and CEO of Electrome Corporation, commented, “BioElectronics’ investment in dedicated fulfillment capacity is an important step as Electrome prepares to introduce ActiPatch to the U.S. direct-to-consumer market in its newly designed packaging. Having an experienced fulfillment partner with direct knowledge of the product, its quality requirements, and the regulatory environment will help us build an efficient and reliable customer experience from the outset.”
The Fulfillment Agreement provides for dedicated onsite storage and fulfillment capacity, including inventory storage, packing and order-processing areas, outbound-order staging, shipping equipment, inventory segregation, and returns processing. BioElectronics will receive monthly storage fees, order-based pick-and-pack fees, and additional fees for certain returns, special projects, inventory services, and non-standard fulfillment activities. The arrangement also includes a monthly minimum charge for pick-and-pack services.
Management believes the expansion provides BioElectronics with a scalable platform to support Electrome’s commercialization efforts while maintaining direct oversight of inventory handling, quality controls, shipping operations, and customer returns. The additional capacity may also support future fulfillment requirements associated with other commercial partners and distribution channels.
BioElectronics Corporation is a medical device company focused on advanced bioelectronic therapies using pulsed shortwave therapy technology for pain management and recovery, with products including ActiPatch, RecoveryRx, and RecoveryRx Veterinary. Electrome Corporation commercializes FDA-cleared pulsed shortwave therapy technology through its PAINKILLER™ platform across multiple channels, with additional bioelectric treatments in development.
